Related Experiment Video
Updated: Jun 4, 2026
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
[Expression of endostatin and its relationship with the clinical pathophysiological characteristics in non-small cell
Ying Liu1, Qinghua Zhou, Shangfu Zhang
1Department of Thoracic and Cardiovascular Surgery, The West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R.China.
Background:
To study the relationship between expression of endostatin and clinical and pathophysiological characteristics in the non-small cell lung cancer (NSCLC).
Methods:
The expression of endostatin was detected in 46 lung cancer tissues and paracancerous lung tissues, 14 benign pulmonary lesion tissues as control by immunohistochemical staining (LSAB method).
Results:
The expression of endostatin in lung cancer tissues (84.91%±7.65%) was significantly higher than that in paracancerous tissues (63.70%±12.45%) and benign pulmonary lesion tissues (40.29%±15.01%) (P < 0.01); The expression of endostatin was closely related to the size of primary tumor, distant metastasis of the cancer, P-TNM stages and cell differentiation of lung cancer (P < 0.05), but not to the histological classification, lymph node status, location of the tumor, smoking or not, age and sex of the patients with lung cancer (P > 0.05).
Conclusions:
The expression of endostatin in NSCLC cancer tissues might be helpful to evaluate the biological behavior of lung cancer.
